Theravance Biopharma Inc. (TBPH)

Sector:Health Care
Super Investor Stats:
Ownership count:1
Ownership rank:687
% of all portfolios:0.023%
History Portfolio Manager Activity Share change % change to portfolio
Q2  2023
Seth Klarman - Baupost Group Reduce 28.79% 3,000,000 0.56
Q1  2023
Seth Klarman - Baupost Group Reduce 8.76% 1,000,000 0.19
Q4  2022
Seth Klarman - Baupost Group Reduce 14.90% 2,000,000 0.38
Q2  2022
Seth Klarman - Baupost Group Reduce 1.64% 224,107 0.03
Q1  2022
Seth Klarman - Baupost Group Reduce 0.12% 16,835 0.00
Q3  2021
Seth Klarman - Baupost Group Add 37.84% 3,750,000 0.26
Q2  2021
Seth Klarman - Baupost Group Add 13.45% 1,175,000 0.14
Q3  2020
Seth Klarman - Baupost Group Reduce 6.17% 574,000 0.09
Q3  2017
Seth Klarman - Baupost Group Add 0.38% 35,177 0.02
Q4  2016
Seth Klarman - Baupost Group Add 26.16% 1,923,000 0.81
Q2  2016
Seth Klarman - Baupost Group Add 13.07% 850,000 0.26
Q1  2016
Seth Klarman - Baupost Group Add 1.26% 80,963 0.02
Q2  2015
Seth Klarman - Baupost Group Add 0.84% 53,451 0.01
Q1  2015
Seth Klarman - Baupost Group Add 5.04% 305,349 0.09
Q2  2014
Seth Klarman - Baupost Group Buy 6,061,228 3.20

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.